Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Oliver

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1991
Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysisJ M Stevens, J Auer, C A Strong, et al.
Calcified Tissue Research|August 1, 1976
Comparative effect of 1alpha-hydroxycholecalciferol in children and adults with renal glomerular osteodystrophyR G Henderson, J A Kanis, J G Ledingham, et al.
British Journal of Haematology|June 1, 1990
Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessmentR T Hughes, P M Cotes, M J Pippard, et al.
The New England Journal of Medicine|May 12, 1977
Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitoninJ A Kanis, M Earnshaw, G Heynen, et al.
Clinical Science and Molecular Medicine|February 1, 1974
Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in manR G Henderson, J G Ledingham, D O Oliver, et al.
British Medical Journal|June 14, 1980
Cancer in patients receiving dialysisL J Kinlen, J B Eastwood, D N Kerr, et al.
Lancet (London, England)|March 9, 1974
Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failureR G Henderson, R G Russell, J G Ledingham, et al.
Contributions to Nephrology|January 1, 1989
Correction of the anaemia of chronic renal failure with erythropoietin: pharmacokinetic studies in patients on haemodialysis and CAPDR T Hughes, P M Cotes, D O Oliver, et al.
Lancet (London, England)|August 10, 1991
Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P componentS R Nelson, P N Hawkins, S Richardson, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1973
1,25-dihydroxycholecalciferol in patients with chronic renal failureR G Henderson, J G Ledingham, A W Norman, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1991
Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysisJ M Stevens, J Auer, C A Strong, et al.
Calcified Tissue Research|August 1, 1976
Comparative effect of 1alpha-hydroxycholecalciferol in children and adults with renal glomerular osteodystrophyR G Henderson, J A Kanis, J G Ledingham, et al.
British Journal of Haematology|June 1, 1990
Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessmentR T Hughes, P M Cotes, M J Pippard, et al.
The New England Journal of Medicine|May 12, 1977
Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitoninJ A Kanis, M Earnshaw, G Heynen, et al.
Clinical Science and Molecular Medicine|February 1, 1974
Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in manR G Henderson, J G Ledingham, D O Oliver, et al.
British Medical Journal|June 14, 1980
Cancer in patients receiving dialysisL J Kinlen, J B Eastwood, D N Kerr, et al.
Lancet (London, England)|March 9, 1974
Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failureR G Henderson, R G Russell, J G Ledingham, et al.
Contributions to Nephrology|January 1, 1989
Correction of the anaemia of chronic renal failure with erythropoietin: pharmacokinetic studies in patients on haemodialysis and CAPDR T Hughes, P M Cotes, D O Oliver, et al.
Lancet (London, England)|August 10, 1991
Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P componentS R Nelson, P N Hawkins, S Richardson, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1973
1,25-dihydroxycholecalciferol in patients with chronic renal failureR G Henderson, J G Ledingham, A W Norman, et al.
Pageof 7